The Sweet PEA Study: Effects of Diet During Pregnancy on Infant Growth and Development.
NCT04674033 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 93
Last updated 2024-12-06
Summary
The purpose of the Sweet PEA Study is to determine whether diet during pregnancy has an effect on infant's growth, body composition, and brain development.
Conditions
Sponsors & Collaborators
-
Children's Hospital Los Angeles
collaborator OTHER -
University of Southern California
lead OTHER
Principal Investigators
-
Michael I Goran · University of Southern California; Children's Hospital Los Angeles
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-01-18
- Primary Completion
- 2020-07-01
- Completion
- 2020-07-01
Countries
- United States
Study Locations
More Related Trials
-
Healthy Diet for Healthy Moms and Babies
NCT03467503 ·Status: COMPLETED ·Phase: NA
-
Exercise and Pregnancy: Randomized Clinical Trial
NCT00641550 ·Status: UNKNOWN ·Phase: NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
NCT02273297 ·Status: RECRUITING
-
Early Prediction and Randomised Prevention of Preeclampsia With Low Dose Aspirin in Chinese Cohort
NCT04631627 ·Status: UNKNOWN ·Phase: PHASE4
-
Maternal Obesity and Small for Gestational Age Infants
NCT00371657 ·Status: COMPLETED
-
L-Arginine and Antioxidant Vitamins During Pregnancy to Reduce Preeclampsia
NCT00469846 ·Status: TERMINATED ·Phase: PHASE2
-
The Effect Of Antenatal Corticosteroids On Early And Late Perinatal Outcomes
NCT06164080 ·Status: COMPLETED ·Phase: NA
-
Low Carb vs Normal Carb in Pregnancy
NCT03749889 ·Status: TERMINATED ·Phase: NA
-
Study of Nicotinamide in Early Onset Preeclampsia
NCT03419364 ·Status: COMPLETED ·Phase: PHASE2
-
Daily Step Count and Achieving Goal Gestational Weight Gain
NCT04605406 ·Status: WITHDRAWN
-
Dose Reduction of Antenatal Betamethasone Given to Prevent the Neonatal Complications Associated With Very Preterm Birth
NCT02897076 ·Status: COMPLETED ·Phase: PHASE3
-
Maternal Adipose Tissue and Placental Dysfunction Programs the Fetus for Type 2 Diabetes (PlacentA-DM)
NCT02211651 ·Status: COMPLETED
-
Preeclampsia Intervention Netherlands
NCT06452498 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Zambian Preterm Birth Prevention Study
NCT02738892 ·Status: ACTIVE_NOT_RECRUITING
-
Baby Bump Lifestyle Intervention Supplement Study
NCT03751813 ·Status: TERMINATED ·Phase: NA
-
Maternal Lipids and Offspring Adiposity at 5-7 Years
NCT03317522 ·Status: COMPLETED
-
Insulin Pre-treatment for Steroid-associated Hyperglycemia in Pregnant Diabetic Patients
NCT01875107 ·Status: WITHDRAWN ·Phase: PHASE4
-
Efficacy and Safety of L Arginine to Prevent Preeclampsia
NCT02363348 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Antenatal Corticosteroids on Neonatal Morbidity.
NCT03446937 ·Status: COMPLETED ·Phase: NA
-
The Effect of Steroids on Maternal Glucose Levels
NCT03021837 ·Status: COMPLETED
-
Effects of Diet on Pregnancy Outcome and Child Obesity
NCT03232762 ·Status: COMPLETED ·Phase: NA
-
Implementation of First-trimester Screening and preventiOn of pREeClAmpSia Trial (FORECAST)
NCT03941886 ·Status: COMPLETED ·Phase: NA
-
Blood Glucose in Pregnant Non-diabetic Women During Treatment With Betamethasone for Fetal Lung Maturation
NCT06794307 ·Status: RECRUITING
-
The Role of Cytokines in Apparently Normal Pregnancies
NCT01098214 ·Status: WITHDRAWN
-
PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia
NCT06033131 ·Status: RECRUITING ·Phase: PHASE3